Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$406M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$351M |
| 3 |
Meta Platforms (Facebook)
META
|
+$316M |
| 4 |
Walmart
WMT
|
+$230M |
| 5 |
ServiceNow
NOW
|
+$217M |
Top Sells
| 1 |
Apple
AAPL
|
+$549M |
| 2 |
Palantir
PLTR
|
+$549M |
| 3 |
Netflix
NFLX
|
+$378M |
| 4 |
NVIDIA
NVDA
|
+$267M |
| 5 |
Alibaba
BABA
|
+$207M |
Sector Composition
| 1 | Technology | 17.41% |
| 2 | Healthcare | 14.96% |
| 3 | Consumer Discretionary | 11.86% |
| 4 | Financials | 11.03% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Society Pass
SOPA
$7.14M
| $79.1K | ﹤0.01% |
87,157
+74,880
| +610% | +$67.9K |
|
3227
Coya Therapeutics
COYA
$106M
| $78.9K | ﹤0.01% |
+12,200
| New | +$78.9K |
|
3228
Carisma Therapeutics
CARM
$16.4M
| $78.6K | ﹤0.01% |
253,657
+22,300
| +10% | +$6.91K |
|
3229
Lotus Technology
LOT
$1.36B
| $77.6K | ﹤0.01% |
+48,500
| New | +$77.6K |
|
3230
US Energy Corp
USEG
$39.8M
| $77.4K | ﹤0.01% |
64,500
+1,600
| +3% | +$1.92K |
|
3231
Vertical Aerospace
EVTL
$479M
| $76.3K | ﹤0.01% |
22,709
+3,909
| +21% | +$13.1K |
|
3232
Grove Collaborative
GROV
$62.7M
| $76.1K | ﹤0.01% |
56,400
+12,900
| +30% | +$17.4K |
|
3233
ProFrac Holding
ACDC
$695M
| $75.9K | ﹤0.01% |
+10,000
| New | +$75.9K |
|
3234
Inovio Pharmaceuticals
INO
$140M
| $74.7K | ﹤0.01% |
45,828
-196,477
| -81% | -$320K |
|
3235
Designer Brands
DBI
$229M
| $74.2K | ﹤0.01% |
+20,330
| New | +$74.2K |
|
3236
Milestone Scientific
MLSS
$46M
| $72.5K | ﹤0.01% |
77,756
-48,519
| -38% | -$45.2K |
|
3237
DarioHealth
DRIO
$18.3M
| $72K | ﹤0.01% |
5,880
+1,295
| +28% | +$15.9K |
|
3238
Getty Images
GETY
$772M
| $71.3K | ﹤0.01% |
41,200
-70,400
| -63% | -$122K |
|
3239
Forian
FORA
$72.2M
| $71.2K | ﹤0.01% |
35,600
+299
| +0.8% | +$598 |
|
|
ZEPP
3240
Zepp Health
ZEPP
$744M
| $70.5K | ﹤0.01% |
23,824
| – | – |
|
3241
Lexeo Therapeutics
LXEO
$281M
| $70.4K | ﹤0.01% |
+20,300
| New | +$70.4K |
|
3242
Sensei Biotherapeutics
SNSE
$10.7M
| $69.9K | ﹤0.01% |
8,865
+1,025
| +13% | +$8.08K |
|
3243
Xenetic Biosciences
XBIO
$4.6M
| $69.9K | ﹤0.01% |
26,764
+1,214
| +5% | +$3.17K |
|
3244
Microvision
MVIS
$334M
| $69.7K | ﹤0.01% |
56,244
-1,294,479
| -96% | -$1.61M |
|
3245
KORE Group Holdings
KORE
$37.6M
| $68.8K | ﹤0.01% |
27,841
+5,200
| +23% | +$12.8K |
|
3246
Freightos
CRGO
$158M
| $68.1K | ﹤0.01% |
+28,500
| New | +$68.1K |
|
3247
Urban One Class A
UONE
$65.3M
| $67.8K | ﹤0.01% |
47,100
+100
| +0.2% | +$144 |
|
|
INCR
3248
Intercure
INCR
$86.1M
| $67.8K | ﹤0.01% |
48,400
+100
| +0.2% | +$140 |
|
3249
CalciMedica
CALC
$48.8M
| $67.6K | ﹤0.01% |
35,416
-7,784
| -18% | -$14.9K |
|
3250
Metalpha Technology Holding
MATH
$128M
| $67.5K | ﹤0.01% |
39,700
| – | – |
|